These are the most recent diaries filed under this tag:
The SimplyThick Infant Formula Experiment Continues SimplyThick necrotizing enterocolitis medical alerts were last issued in September 2012. In spite of these health risk notifications SimplyThick ...
by Lynne Vogel
Comment Count 9 comments on Mon Sep 02, 2013 at 04:50 PM PDT with 1 Recommend
Xanthan Gum Pharmaceutical Applications Xanthan gum, derived from the gram-negative xanthomonas campestris bacterium , is a common excipient in prescription drugs and over-the counter medications.
by Lynne Vogel
Comment Count 56 comments on Tue May 14, 2013 at 05:59 PM PDT with 28 Recommends
John L. Holahan—2013 SimplyThick® Necrotizing Enterocolitis Risk Update SimplyThick® president John L. Holahan is currently advising that: WARNING - [SimpyThick] NOT intended for use with ...
by Lynne Vogel
Comment Count 4 comments on Sat Feb 23, 2013 at 03:27 PM PST with 4 Recommends
John L. Holahan—SimplyThick®—Xanthan Gum John L. Holahan , SimplyThick® president/patent holder, showcased his xanthan gum adult dysphagia-treatment product at the American Dietetic ...
by Lynne Vogel
Comment Count 15 comments on Sun Jan 27, 2013 at 03:26 PM PST with 5 Recommends
SimplyThick®—John L. Holahan SimplyThick® entered the health care market in 200l as a dysphagia -treatment therapy. John L. Holahan was granted a patent for the SimplyThick® beverage ...
by Lynne Vogel
Comment Count 11 comments on Sun Dec 23, 2012 at 03:48 PM PST with 1 Recommend
Xanthan gum, a biotechnology product, was invented by the research team of Allene Rosalind Jeanes of the United States Department of Agriculture. This polysaccharide was approved as a food ...
by Lynne Vogel
Comment Count 16 comments on Sun Nov 25, 2012 at 06:22 PM PST with 17 Recommends